Evidence map›Paper›PMID 34354593›Full record

ArticleFrontiers in pharmacology2021

Antileishmanial Activity of Flavones-Rich Fraction From

João Victor Silva-Silva, Carla Junqueira Moragas-Tellis, Maria do Socorro Dos Santos Chagas, Paulo Victor Ramos de Souza, Celeste da Silva Freitas de Souza, Daiana de Jesus Hardoim, Noemi Nosomi Taniwaki, Davyson de Lima Moreira, Maria Dutra Behrens, Kátia da Silva Calabrese and 1 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. In vitro Anti-Leishmanial Activities of Methanol Extract ofJournal of experimental pharmacology · 2023
    Article
  7. Article
  8. Carajurin Induces Apoptosis inPharmaceuticals (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Monomethylsulochrin isolated from biomass extract ofFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

João Victor Silva-SilvaLaboratory of Immunomodulation and Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Carla Junqueira Moragas-TellisLaboratory of Natural Products for Public Health, Pharmaceutical Techonology Institute - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Maria do Socorro Dos Santos ChagasLaboratory of Natural Products for Public Health, Pharmaceutical Techonology Institute - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Paulo Victor Ramos de SouzaLaboratory of Natural Products for Public Health, Pharmaceutical Techonology Institute - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Celeste da Silva Freitas de SouzaLaboratory of Immunomodulation and Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Daiana de Jesus HardoimLaboratory of Immunomodulation and Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Noemi Nosomi TaniwakiElectron Microscopy Nucleus, Adolfo Lutz Institute, São Paulo, Brazil.
Davyson de Lima MoreiraLaboratory of Natural Products for Public Health, Pharmaceutical Techonology Institute - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Maria Dutra BehrensLaboratory of Natural Products for Public Health, Pharmaceutical Techonology Institute - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Kátia da Silva CalabreseLaboratory of Immunomodulation and Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Fernando Almeida-SouzaLaboratory of Immunomodulation and Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acknowledging the need of identifying new compounds for the treatment of leishmaniasis, this study aimed to evaluate, from

Indexed as

Arrabidaea chicaflavonoidsL. amazonensismacrophagesnitric oxidetransmission electron microscopy

Identifiers

PMID34354593
PMCPMC8329660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.